Name: Aardvark Therapeutics, Inc. (AARD) Cash Flow Statement
Creator: FinSpry

Aardvark Therapeutics Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for Aardvark Therapeutics, Inc. (AARD) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022
Period Ending	Dec 2024	Dec 2023	Dec 2022
Operating Activities
Net Income	-20.59	-7.21	-13.56
Depreciation & Amortization	0.02	0.00	0.11
Stock Based Compensation	0.44	0.31	0.41
Change in Working Capital	1.57	-0.08	-1.31
Change in Accounts Payable	0.80	0.78	0.03
Change in Other Working Capital	0.24	-0.86	1.00
Other Operating Activities	0.24	-0.83	1.00
Net Cash from Operating Activities	-18.09	-5.82	-10.54
Investing Activities
Capital Expenditures	-0.11	0.00	0.00
Purchases of Investments	-11.89	0.00	0.00
Other Investing Activities	0.00	0.00	-1.00
Net Cash from Investing Activities	-12.00	0.00	-1.00
Financing Activities
Common Stock Issued	0.33	0.00	0.23
Other Financing Activities	-3.34	0.00	0.00
Net Cash from Financing Activities	81.99	0.00	0.23
Summary
Net Change in Cash	51.91	-5.82	-11.32
Cash at Beginning of Period	9.74	15.56	26.88
Cash at End of Period	61.64	9.74	15.56
Free Cash Flow	-18.20	-5.82	-10.54